Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent~* Outpatient at least 12 years of age with diagnosis of asthma at least 12 weeks prior to first visit~* Both genders; females of child bearing potential must be willing to use appropriate contraception~* Pre-bronchodilator FEV1 of 40-90% predicted~* Reversibility FEV1 of at least 12% and 200mLs~* Current asthma therapy that includes inhaled corticosteroid for at least 4 weeks prior to first visit~Exclusion Criteria:~* History of life threatening asthma~* Respiratory infection or candidiasis~* Asthma exacerbation requiring OCS within last 4 weeks or overnight hospital stay within the last 3 months~* Concurrent respiratory disease or other disease that would confound study participation of affect subject safety~* Allergies to study drugs, study drug excipients, medications related to study drugs~* Taking another investigational medication or medication prohibited for use during the study~* Previous treatment with FF or FF/VI in a phase II or III study~* Night shift workers~* Children in care

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- FF 100mcg once daily (Type: EXPERIMENTAL): Inhaled corticosteroid (ICS)
- FF 200mcg once daily (Type: EXPERIMENTAL): Inhaled corticosteroid

Based on this trial design, predict the completion outcome and termination type (if applicable).